Monte Rosa Therapeutics, Inc. (GLUE) Ownership

$6.89

south_east
-$0.28 (-3.91%)
Day's range
$6.88
Day's range
$7.3

Monte Rosa Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
NEA MANAGEMENT COMPANY, LLC 02/14/2025 7.69 M $53.38 M   0.00% 9.38%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 7.12 M $49.39 M   7.81% 8.68%
VERSANT VENTURE MANAGEMENT, LLC 02/12/2025 5.65 M $39.23 M   100.00% 6.89%
FMR LLC 02/13/2025 5.55 M $38.51 M   8.76% 6.77%
BAKER BROS. ADVISORS LP 02/14/2025 4.92 M $34.12 M   0.00% 5.99%
AVORO CAPITAL ADVISORS LLC 02/14/2025 4.35 M $30.15 M   -24.96% 5.30%
BLACKROCK FUNDING, INC. /DE 02/07/2025 3.84 M $26.65 M   32.35% 4.68%
VANGUARD GROUP INC 02/11/2025 3.16 M $21.91 M   24.55% 3.85%
BVF INC/IL 02/14/2025 2.76 M $19.19 M   100.00% 3.37%
SUVRETTA CAPITAL MANAGEMENT, LLC 02/14/2025 1.56 M $10.85 M   -41.19% 1.91%
AISLING CAPITAL MANAGEMENT LP 02/12/2025 1.47 M $10.22 M   0.00% 1.80%
ALPHABET INC. 02/07/2025 1.46 M $10.16 M   0.00% 1.79%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.04 M $7.20 M   -0.77% 1.26%
MARSHALL WACE, LLP 02/13/2025 499,492 $3.47 M   187.31% 0.61%
NORGES BANK 02/12/2025 445,868 $3.09 M   100.00% 0.54%
VESTAL POINT CAPITAL, LP 02/14/2025 425,000 $2.95 M   -54.30% 0.52%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 370,472 $2.57 M   6.92% 0.45%
PARKWOOD LLC 02/14/2025 323,000 $2.24 M   -24.29% 0.39%
IKARIAN CAPITAL, LLC 02/14/2025 311,575 $2.16 M   -0.01% 0.38%
TWO SIGMA INVESTMENTS, LP 02/14/2025 278,785 $1.93 M   1,965.07% 0.34%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 245,700 $1.71 M   12.35% 0.30%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 221,741 $1.54 M   2.18% 0.27%
TD ASSET MANAGEMENT INC 02/11/2025 220,096 $1.53 M   13.63% 0.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 193,500 $1.34 M   172.15% 0.24%
BANK OF NEW YORK MELLON CORP 02/04/2025 170,312 $1.18 M   2.17% 0.21%
GOLDMAN SACHS GROUP INC 02/11/2025 159,874 $1.11 M   -10.49% 0.19%
JUMP FINANCIAL, LLC 02/13/2025 154,842 $1.07 M   100.00% 0.19%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 144,811 $1.00 M   3.98% 0.18%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 117,412 $814,839   -0.39% 0.14%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 102,835 $713,675   0.00% 0.13%
QUEST PARTNERS LLC 02/07/2025 94,633 $656,753   100.00% 0.12%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 92,818 $644,156   100.00% 0.11%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 91,274 $633,442   -0.02% 0.11%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 86,545 $600,622   100.00% 0.11%
CASDIN CAPITAL, LLC 02/14/2025 86,014 $596,937   0.00% 0.10%
AMERICAN CENTURY COMPANIES INC 02/11/2025 76,850 $533,339   27.31% 0.09%
BARCLAYS PLC 02/13/2025 70,741 $491,000   29.78% 0.09%
WELLS FARGO & COMPANY/MN 02/13/2025 70,162 $486,925   215.90% 0.09%
D. E. SHAW & CO., INC. 02/14/2025 70,114 $486,591   283.33% 0.09%
RHUMBLINE ADVISERS 01/30/2025 61,791 $428,821   17.77% 0.08%
UBS GROUP AG 02/14/2025 59,399 $412,229   134.47% 0.07%
MILLENNIUM MANAGEMENT LLC 02/14/2025 46,370 $321,808   51.43% 0.06%
CITIGROUP INC 02/12/2025 44,883 $311,489   49.10% 0.05%
LONG CORRIDOR ASSET MANAGEMENT LTD 02/12/2025 40,000 $277,600   0.00% 0.05%
WALLEYE CAPITAL LLC 02/13/2025 39,647 $275,150   100.00% 0.05%
ALLIANCEBERNSTEIN L.P. 02/12/2025 35,140 $243,872   0.00% 0.04%
STATE OF WISCONSIN INVESTMENT BOARD 02/14/2025 32,382 $224,731   -10.79% 0.04%
CORTON CAPITAL INC. 02/14/2025 32,366 $224,620   100.00% 0.04%
SQUAREPOINT OPS LLC 02/14/2025 31,654 $219,679   100.00% 0.04%
EXCHANGE TRADED CONCEPTS, LLC 01/21/2025 29,798 $206,798   0.00% 0.04%

Monte Rosa Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 111 institutional investors and hedge funds held shares of Monte Rosa Therapeutics, Inc.. The most heavily invested institutionals were:

NEA Management Company, LLC: 7.69 M

PRICE T ROWE ASSOCIATES INC /MD/: 7.12 M

Versant Venture Management, LLC: 5.65 M

FMR LLC: 5.55 M

BAKER BROS. ADVISORS LP: 4.92 M

Avoro Capital Advisors LLC: 4.35 M

74.36% of Monte Rosa Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 60.50 M shares in the last 24 months. This purchase volume represents approximately $416.84 M in transactions.